EP300

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA003128

Antibody HPA004112

Antibody CAB000146

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A majority of malignant tissues displayed moderate to strong nuclear immunoreactivity. Moderate to strong nuclear immunoreactivity was observed in most malignant cells. Additional cytoplasmic positivity was observed in a majority of cases. Weak to moderate nuclear positivity was seen in most malignancies.

Validation

Supportive: One antibody yielding a staining pattern which is consistent with gene/protein characterization data
Supportive: One antibody yielding a staining pattern which is consistent with gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected